CAGE-AID: A Practical Guide for Australian Pharmacists
The Pharmacist's Guide to Using the CAGE-AID Screening Tool for Substance Use Disorders explains how a brief four-question screen can support conversations about alcohol and other drug use. CAGE-AID is not a diagnosis. It gives pharmacists a structured way to identify possible problematic use, begin a respectful discussion and decide when fuller assessment or referral is needed.
Community pharmacies are often the first accessible healthcare contact for many Australians. A person collecting repeats from a Sydney or Melbourne chemist, or asking for advice in a regional town, may not have planned an appointment but may welcome a private conversation. Pharmacists can also identify patterns across prescription and over-the-counter purchases without assuming that every substance dispensed has been misused.
This guide covers preparation, question wording, scoring, follow-up and documentation. It places CAGE-AID within brief intervention and referral practice while distinguishing screening from clinical assessment. It also considers confidentiality, Australian treatment pathways and the wellbeing of pharmacy staff, because screening improves care only when the response is safe, respectful and feasible.
What CAGE-AID measures and does not measure
CAGE-AID grew from CAGE, a brief alcohol screen built around four clinical ideas: cutting down, feeling annoyed by criticism, feeling guilty, and using alcohol to sober up. The AID adaptation extends the questions to alcohol and other drug use. It is therefore particularly useful when a pharmacist needs one short approach across substances rather than separate conversations for each drug.
The tool samples behaviours associated with possible dependence, including loss of control, defensiveness, remorse and continued use despite harm. It does not measure every DSM-5 criterion for a substance use disorder, establish a pattern over 12 months, or reveal the quantity consumed. A positive response can prompt useful questions, but it cannot establish severity on its own.
Other validated tools may be more suitable for the concern being presented. AUDIT-C can screen alcohol risk, while DAST-10 covers drug use; a tobacco-specific measure may be preferable for nicotine dependence. Use the version your service has approved, avoid changing individual items without evidence, and record which instrument was used so another clinician can interpret the result.
Preparing for a private and respectful conversation
Begin in a way that protects dignity. At a busy counter in a Sydney shopping centre or a small regional pharmacy, even a quiet request for privacy may reveal the nature of the discussion. Offer a confidential space where available, reduce interruptions and check whether the person wants a five-minute screening or a longer appointment. Asking permission keeps the encounter voluntary and signals respect.
Explain what will happen with the answers. The Privacy Act 1988 (Cth), applicable state and territory health-records laws, professional obligations and records policies may all matter. A pharmacist must not promise absolute secrecy: information may need to be shared for an imminent safety concern, child protection or another legally required purpose. Record consent for referrals and explain any limits before screening.
Use an interpreter when language or communication needs make the questions unclear, and seek a culturally safe response for Aboriginal and Torres Strait Islander clients and people from diverse backgrounds. Avoid family members as ad hoc interpreters when sensitive issues are involved. Communication coaching and pharmacy-practice reflection from Johnathan Laird's pharmacy perspectives can help teams practise this language before using it in a busy dispensary.
Asking the questions and recording the score
Read the questions in the same order, with the same meaning, each time. The gateway question is: “Have you had a drink or used drugs in the last six months?” A “no” normally ends the short screen and gives a total score of zero; a “yes” means the remaining questions apply. Frame it as information about health, not an accusation about drug use.
The follow-up questions ask: “Do you feel annoyed or irritated by criticisms of your drinking or drug use?”; “Do you feel guilty or remorseful about your drinking or drug use?”; and “Do you sometimes drink or use drugs just to sober up?” These items should be asked about the substances the person actually uses. Do not silently replace “drugs” with illicit drugs, because prescribed opioids, cannabis, stimulants and other substances may all be relevant.
Allow time for each answer, and ask permission before clarifying anything that sounds unusual. “Just to sober up” may need an explanation of its ordinary meaning without supplying examples that cue the response. If the person appears intoxicated, confused or unable to give a reliable answer, defer the formal screen and address immediate safety. A brief, candid statement of what you noticed is usually better than a blunt label.
Interpreting results with clinical caution
Check the scoring guide that accompanies your chosen version. In a common method, a “yes” to recent use counts one point and each “yes” to the final three questions counts one, producing a range from zero to four. Some services treat recent use only as an entry criterion and score the final three questions. Do not mix systems. A total of two or more commonly prompts fuller assessment, but local protocols may differ and the threshold is not a diagnosis.
A score of zero or one generally indicates that the CAGE-AID questions did not identify the dependence features they sample, yet significant harm can still be present. Quantity, frequency, loss of control, withdrawal, impaired driving, mental health effects and consequences at work or home need separate exploration. Conversely, defensiveness or remorse may be influenced by shame, family conflict or grief, so a score should never be treated as proof of a disorder.
Assess immediate safety before debating the score. If the person is severely drowsy, confused, breathing slowly or unable to be awakened, call 000, do not leave them alone and use naloxone if it is available and you are trained. Take-home naloxone is available through many Australian pharmacies, although supply, cost and eligibility differ by state and programme. Any suspected overdose, severe withdrawal or imminent self-harm requires urgent medical help rather than routine screening.
Delivering a brief intervention
After screening, a brief intervention can turn a concerning score into practical support. Ask permission to discuss your observations, state the concern clearly, offer information and invite the person to choose a next step. For example: “I noticed you have found drinking harder to control. What impact is it having on your sleep, work or medications?” This approach conveys concern without asserting that the person has an addiction.
Motivational interviewing provides a useful structure: ask an open question, affirm the person's existing goals, reflect what you have heard, and summarise the agreed plan. Avoid confrontation, scare tactics or attempts to impose a label. If the person is not ready to change, offer one achievable harm-reduction step and leave the door open for a later discussion. Consistency across visits can matter more than securing an immediate decision.
Medication review is a distinct pharmacist contribution. Ask about alcohol alongside opioids, benzodiazepines, sedating antihistamines and other medicines that may increase sedation, falls or breathing risk. Flag unsafe combinations to the prescriber, provide written instructions and naloxone information when indicated, and never advise abrupt discontinuation of benzodiazepines without coordinated clinical care. Harm reduction also includes safer storage, preventing access by children and linking the person with peer support.
Making referrals and protecting continuity
Refer according to urgency, preference and the substance involved. Offer a general practitioner, local alcohol and other drug service, mental health professional, pharmacist prescriber where appropriate, or a specialist treatment service. With consent, make a warm handoff or book the appointment rather than simply handing over a phone number. The national alcohol and drug helpline on 1800 250 015 can direct people to local services; urgent overdose and medical emergencies still require 000.
Explain public and subsidised pathways in plain language. People eligible for Medicare may access a Medication Treatment Program for opioid use disorder through an authorised prescriber, while opioid agonist treatment is dispensed through approved pharmacies in many parts of Australia under state law and board requirements. The Pharmaceutical Benefits Scheme covers many medicines, but access does not remove the need for assessment and psychosocial support. Offer an Aboriginal and Torres Strait Islander health service or culturally safe referral where this would be preferred.
Document in the approved clinical record: the substance and words used by the client, each response, the score and version, relevant clinical information, your response to any risk, consent, referral and follow-up plan. Keep documentation factual and avoid unnecessary detail. Share information only for care, safety or another lawful purpose. Accurate records let another pharmacist continue the conversation without making the client repeat a sensitive disclosure.
Hard conversations can affect the team as well as the client. Pharmacy managers can provide debriefing, workload support and confidential employee assistance and counselling through StartuANIT's workplace support. Set a clear process for urgent handover during a shift, and make sure colleagues know who is authorised to coordinate care. A sustainable screening programme depends on support as much as on clinical skill.
Put the CAGE-AID questions, a private-space procedure and local referral contacts where the whole team can find them. Practise scoring the same way, agree who follows up and protect time for the conversation so screening does not become a task performed without support.
The next client response matters more than a polished script. Ask with consent, listen for the substance and consequences behind each answer, respond without judgement, and connect risk with the right care. When a pharmacist raises concern, that concern becomes useful when it leads to safety, practical change and continuity.